Literature DB >> 10996546

Hypocholesterolemic activity of dipyridamole: effects on chick plasma and lipoprotein composition and arachidonic acid levels.

.   

Abstract

We have studied the effects of dipyridamole treatment on chick plasma and lipoprotein composition in postprandial and fasting (12 h) conditions. Plasma cholesterol levels were higher in fasted than in fed chicks, whereas triglycerides declined during starvation. Dipyridamole treatment reduced plasma cholesterol content, mainly of the free cholesterol fraction. In postprandial conditions, total cholesterol content of high and low density lipoproteins decreased in a similar proportion to that observed in plasma. However, cholesterol and other chemical constituents of intermediate and very low density lipoproteins were more drastically reduced by dipyridamole than in plasma. Total amounts of these lipoprotein fractions were also reduced about 50%. The effects of dipyridamole in fasted animals were not significant. To our knowledge, this is one of the first reports about the response of lipoprotein cholesterol to dipyridamole treatment. A strong decrease was also found in the arachidonic acid content of plasma phospholipids and cholesterol esters fractions.

Entities:  

Year:  2000        PMID: 10996546     DOI: 10.1016/s1382-6689(00)00051-x

Source DB:  PubMed          Journal:  Environ Toxicol Pharmacol        ISSN: 1382-6689            Impact factor:   4.860


  2 in total

1.  Jejunal wall triglyceride concentration of morbidly obese persons is lower in those with type 2 diabetes mellitus.

Authors:  F Soriguer; S García-Serrano; L Garrido-Sánchez; C Gutierrez-Repiso; G Rojo-Martínez; E Garcia-Escobar; J García-Arnés; J L Gallego-Perales; V Delgado; Eduardo García-Fuentes
Journal:  J Lipid Res       Date:  2010-09-20       Impact factor: 5.922

2.  Antihyperlipidaemic and hepatoprotective activities of acidic and enzymatic hydrolysis exopolysaccharides from Pleurotus eryngii SI-04.

Authors:  Chen Zhang; Juan Li; Jing Wang; Xingling Song; Jianjun Zhang; Shang Wu; Chunlong Hu; Zhiyuan Gong; Le Jia
Journal:  BMC Complement Altern Med       Date:  2017-08-14       Impact factor: 3.659

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.